The drug givinostat - used for Duchenne Muscular Dystrophy management - remains unavailable to boys and young men who can no ...
Orphan Drug Designation (ODD) recognizes Duchenne muscular dystrophy as a rare disease with significant unmet medical need without an established ...
The father of a boy with a muscle-wasting disease has said he is "incredibly happy" that his son will now get access to a new ...
23h
Does FDA Priority Review for First LGMD Therapy Change The Bull Case For BridgeBio Pharma (BBIO)?
BridgeBio Pharma recently announced that the FDA has accepted and granted Priority Review to its New Drug Application for oral BBP-418 to treat limb-girdle muscular dystrophy type 2I/R9, with a PDUFA ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
The Microscope Ball is the flagship fundraising event for Muscular Dystrophy UK and has raised almost £8 million for the charity to date. Cathey Cullum, Special Events Manager at Muscular Dystrophy UK ...
Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has entered into an agreement ...
Managing the transition to mobility aids is a pivotal part of life with DMD. Discover expert strategies for maintaining independence through physical therapy, adaptive technology, and home ...
The Bolton News on MSN
Team preparing to tackle the Lancashire 'Three Peaks' challenge
A Bolton fitness team is taking on a 20km moorland trek across the West Pennine Moors to raise money for Muscular Dystrophy ...
DUBLIN--(BUSINESS WIRE)--The "Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results